List Results  
  Refine Search  
  Results by Topic  
  Results on Map  
  Search Details  
Found 302 studies with search of:   Open Studies | "Ovarian Neoplasms"
  Display Options
Rank Status Study
1 Recruiting AZD0530 Phase II Study in Patients With Advanced Ovarian Cancer
Conditions: Ovarian Neoplasms;   Ovarian Cancer
Interventions: Drug: AZD0530;   Drug: Carboplatin;   Drug: Paclitaxel
2 Recruiting MK4827 in Patients With Advanced Solid Tumors and BRCA Mutant Ovarian Cancer
Conditions: Solid Tumors and Ovarian Neoplasms;   Ovarian Neoplasms
Intervention: Drug: Comparator: MK4827 (PARP inhibitor)
3 Recruiting A Phase 1 Study of the Safety and Pharmacokinetics of AGS-8M4 in Subjects With Advanced Ovarian Cancer
Conditions: Carcinoma;   Ovarian Cancer;   Ovarian Diseases;   Ovarian Neoplasms
Intervention: Biological: AGS-8M4
4 Recruiting AZD2281 and Carboplatin in Treating Patients With BRCA1/BRCA2-Associated or Hereditary Metastatic or Unresectable Breast and/or Ovarian Cancer
Conditions: brca1 Mutation Carrier;   brca2 Mutation Carrier;   Breast Cancer;   Hereditary Breast/Ovarian Cancer (brca1, brca2);   Ovarian Cancer
Interventions: Drug: PARP inhibitor AZD2281;   Drug: carboplatin;   Procedure: immunoenzyme technique;   Procedure: laboratory biomarker analysis;   Procedure: mutation analysis;   Procedure: polymorphism analysis
5 Recruiting Study of Individuals and Families at High Risk for Breast or Ovarian Cancer
Conditions: Breast Cancer;   Hereditary Breast/Ovarian Cancer (brca1, brca2);   Ovarian Cancer
Interventions: Procedure: biopsy;   Procedure: breast duct lavage;   Procedure: breast imaging study;   Procedure: gene mapping;   Procedure: magnetic resonance imaging;   Procedure: mammography;   Procedure: mutation analysis;   Procedure: questionnaire administration;   Procedure: study of high risk factors
6 Recruiting Ovarian Cancer Early Detection Program Screening Study
Conditions: Hereditary Breast/Ovarian Cancer (brca1, brca2);   Ovarian Cancer
Interventions: Procedure: chromosomal translocation analysis;   Procedure: comparative genomic hybridization;   Procedure: cytology specimen collection procedure;   Procedure: laboratory biomarker analysis;   Procedure: laparoscopy;   Procedure: microsatellite instability analysis;   Procedure: mutation analysis;   Procedure: ovarian Papanicolaou test;   Procedure: polymorphic microsatellite marker analysis;   Procedure: study of high risk factors
7 Recruiting Evaluation of Vasopressin in the Vessels of Ovarian Neoplasms
Condition: Ovarian Neoplasms
Intervention: Procedure: removal of ovarian vessels
8 Recruiting Neoadjuvant Chemotherapy With Carboplatin and Docetaxel in Patients With Advanced Ovarian Cancer-Prospective, Randomized Phase II Clinical Trial
Condition: Ovarian Neoplasms
Interventions: Procedure: neoadjuvant chemotherapy (Carboplatin/Docetaxel);   Procedure: neoadjuvant chemotherapy (Carboplatin/Docetaxel)
9 Recruiting Dose-Finding Study Comparing Efficacy and Safety of a PARP Inhibitor Against Doxil in BRCA+ve Advanced Ovarian Cancer
Condition: Ovarian Neoplasms
Interventions: Drug: AZD2281;   Drug: Liposomal Doxorubicin;   Drug: AZD2281
10 Recruiting Microvascular Ultrasonographic Imaging for the Detection of Early Stage Epithelial Ovarian Carcinoma
Condition: Ovarian Neoplasms
Intervention:
11 Not yet recruiting Pharmacogenomics of Paclitaxel in Ovarian Cancer
Conditions: Ovarian Neoplasms;   Fallopian Tube Neoplasms
Intervention:
12 Recruiting Pharmacogenomics of Paclitaxel in Ovarian Cancer
Conditions: Ovarian Neoplasms;   Fallopian Tube Neoplasms
Intervention:
13 Recruiting Safety and Efficacy of EGEN-001 Combined With Carboplatin and Docetaxel in Recurrent, Platinum-Sensitive, Ovarian Cancer
Condition: Ovarian Neoplasms
Intervention: Genetic: EGEN-001 (phIL-12-005/PPC)
14 Not yet recruiting Study of AMG 479 as Second Line Therapy in Patients With Recurrent Platinum-Sensitive Ovarian Cancer
Condition: Ovarian Neoplasms
Intervention: Biological: AMG 479
15 Not yet recruiting Study of Adding AMG 479 to First Line Chemotherapy in Patients With Optimally Debulked Epithelial Ovarian Cancer
Condition: Ovarian Neoplasms
Interventions: Drug: AMG 479;   Drug: AMG 479 Placebo
16 Recruiting Cost Utility Analysis in Recurrent Ovarian Cancer
Condition: Ovarian Cancer
Intervention: Behavioral: Questionnaire
17 Recruiting DOXIL for Consolidation Therapy in Ovarian Cancer.
Condition: Ovarian Neoplasm
Intervention: Drug: liposomal doxorubicin
18 Recruiting An Efficacy and Safety Study of MORAb-003 in First Platinum-Resistant or Refractory Relapsed Ovarian Cancer
Condition: Ovarian Cancer
Interventions: Drug: MORAb-003 (farletuzumab);   Drug: 0.9% Saline
19 Recruiting Data Collection for Patients With Low Grade Ovarian Carcinoma
Conditions: Ovarian Cancer;   Peritoneum Tumors
Intervention: Behavioral: Data Collection
20 Recruiting Study of the Trifunctional Antibody Catumaxomab to Treat Recurrent Symptomatic Malignant Ascites
Conditions: Ovarian Neoplasms;   Ascites
Intervention: Drug: catumaxomab

Previous Page Studies Shown (1-20) Next (21-40)
  RSS Feed for studies found by your search that were received in the last 14 days
  Download Options




U.S. National Library of Medicine,  Contact Help Desk
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services